EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft Rejection (Q62105805)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | EZ-2053 in the Prophylaxis of Acute Pulmonary Allograft Rejection |
clinical trial |
Statements
A Double-Blind, Placebo-Controlled, Multicenter, Dose-Ranging Study of an Anti-human-T-lymphocyte Immune Globulin (EZ-2053) in the Prophylaxis of Acute Pulmonary Allograft Rejection in Adult Recipients of Primary Pulmonary Allograft(s) (English)
0 references
January 2005
0 references
January 2010
0 references
223
0 references